SUGT1 and carcinoma: Notably, Sanger sequencing and BLAST analyses among the amplicons produced from cDNA of polyps and carcinomas and MRPS31P5 showed higher sequence identity (100% similarity) than the fusion MRPS31-SUGT1 (90% similarity with exon 6 of MRPS31 and 98% similarity with exon 3 of SUGT1).